M
Meghna Desai
Researcher at Centers for Disease Control and Prevention
Publications - 14
Citations - 355
Meghna Desai is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Malaria & Dihydroartemisinin/piperaquine. The author has an hindex of 7, co-authored 14 publications receiving 254 citations. Previous affiliations of Meghna Desai include University of Amsterdam & Kenya Medical Research Institute.
Papers
More filters
Journal ArticleDOI
Prevention of malaria in pregnancy
Meghna Desai,Jenny Hill,Silke Fernandes,Patrick G T Walker,Christopher Pell,Julie Gutman,Kassoum Kayentao,Raquel González,Jayne Webster,Brian Greenwood,Michel Cot,Feiko O. ter Kuile +11 more
TL;DR: Modelling analysis suggests the importance of the prevention of malaria early in pregnancy and the need to protect pregnant women declines more slowly than the rate at which transmission declines, as coverage of IPTp and insecticide-treated nets continues to lag behind targets.
Journal ArticleDOI
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis
Anna Maria van Eijk,David A. Larsen,Kassoum Kayentao,Gibby Koshy,Douglas E C Slaughter,Cally Roper,Lucy C Okell,Meghna Desai,Julie Gutman,Carole Khairallah,Stephen J. Rogerson,Carol Hopkins Sibley,Carol Hopkins Sibley,Steven R. Meshnick,Steve M. Taylor,Steve M. Taylor,Feiko O. ter Kuile +16 more
TL;DR: The effectiveness of sulfadoxine-pyrimethamine IPTp is reduced in areas with high resistance to sulfad Oxine- pyrimetamine among P falciparum parasites, but remains associated with reductions in low birthweight even in areas where dhps Lys540Glu prevalence exceeds 90% but where the sextuple-mutant parasite (harbouring the additional dhps Ala581Gly mutation) is uncommon.
Journal ArticleDOI
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya.
Meghna Desai,Meghna Desai,Joanne V Mei,Simon Kariuki,Kathleen Wannemuehler,Penelope A. Phillips-Howard,Bernard L. Nahlen,Piet A. Kager,John M. Vulule,Feiko O. ter Kuile,Feiko O. ter Kuile +10 more
TL;DR: Although IPT prevented malaria, the hematological benefit it added to that of a single dose of SP and bednet use was modest, and the combination of IPT and iron supplementation was most effective in the treatment of mild anemia.
Journal ArticleDOI
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia
Titus K Kwambai,Aggrey Dhabangi,Richard Idro,Robert O. Opoka,Victoria Watson,Simon Kariuki,Nickline A Kuya,Eric D Onyango,Kephas Otieno,Aaron M. Samuels,Meghna Desai,Michael Boele van Hensbroek,Duolao Wang,Chandy C. John,Bjarne Robberstad,Kamija S. Phiri,Feiko O. ter Kuile +16 more
TL;DR: In areas with intense malaria transmission, 3 months of postdischarge malaria chemoprevention with monthly dihydroartemisinin-piperaquine in children who had recently received treatment for severe anemia prevented more deaths or readmissions for any reason after discharge than placebo.
Journal ArticleDOI
A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013
Urbanus Kioko,Christina Riley,Stephanie Dellicour,Vincent Were,Peter Ouma,Julie Gutman,Simon Kariuki,Ahmeddin H Omar,Meghna Desai,Ann M. Buff +9 more
TL;DR: Most outlets never stocked RDTs; therefore, testing prior to treatment was unlikely for customers seeking treatment in the private retail sector, and interventions that create community demand for malaria diagnostic testing before to treatment and that increase RDT availability should be encouraged.